Application of short peptide to preparation of immunoregulation medicament
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- SHANGHAI JIAOTONG UNIV SCHOOL OF MEDICINE
- Publication Date
- 2018-10-23
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of biomedicine, and more specifically, the invention relates to the application of short peptide miPEP155 in the preparation of immunomodulatory drugs. Background technique
[0002] Th17 cells (T helper cell17, Th17) are a newly discovered T cell subset capable of secreting interleukin 17 (interleukin 17, IL-17), Th17 is differentiated by T0 cells under the stimulation of IL-6 and IL-23 Helper T cells, RORγ is an important transcription factor. Th17 cells can secrete and produce IL-17A, IL-17F, IL-6 and tumor necrosis factor a (tumor necrosis factora, TNF-a), etc. These cytokines can collectively mobilize, recruit and activate neutrophils, thus effectively It mediates the inflammatory response of tissues, so Th17 plays an important role in autoimmune diseases and body defense responses.
[0003] Studies have shown that Th17 is closely related to autoimmune diseases such as psoriasis, autoimmune encephalitis, asthma,...